World's Best Scientists 2026 revealed!
Linda A. DiMeglio

Linda A. DiMeglio

D-Index & Metrics

Medicine

D-Index
76
Citations
24632
World Ranking
18687
National Ranking
9309

Linda A. DiMeglio publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Linda A. DiMeglio sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 267 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Linda A. DiMeglio D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Linda A. DiMeglio sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Linda A. DiMeglio is affiliated with Indiana University in the United States and has contributed extensively to the field of medical research, focusing primarily on diabetes and related metabolic disorders. Their body of work encompasses over three hundred publications, with a significant emphasis on endocrinology, genetics, and pediatrics.

Their research primarily addresses key topics including:

  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Gestational Diabetes Research and Management
  • Diet and metabolism studies

Linda A. DiMeglio's expertise spans main fields of study such as Medicine and Biochemistry, Genetics and Molecular Biology. Subfields of particular focus include Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Pediatrics, Perinatology and Child Health, and Public Health, Environmental and Occupational Health.

Their frequent publication venues illustrate the core platforms for their research dissemination:

  • Diabetes
  • Diabetes Care
  • Communications Medicine
  • Pediatric Diabetes
  • Journal of the Endocrine Society

Linda A. DiMeglio has collaborated frequently with a number of researchers, including Carmella Evans-Molina, Heba M. Ismail, Stephen E. Gitelman, Ingrid Libman, and Laura M. Jacobsen. These recurring partnerships reflect a networked approach in advancing their research agenda.

Notable recent publications authored or co-authored include:

  • Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals, 2021, Science Translational Medicine
  • 100 years of insulin: celebrating the past, present and future of diabetes therapy, 2021, Nature Medicine
  • ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes, 2022, Pediatric Diabetes
  • Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine, 2023, Nature Medicine
  • Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes, 2023, JAMA

These works contribute to understanding diabetes pathophysiology, clinical guidelines for glycemic control, and emerging therapeutic approaches. The topics span clinical trials, consensus guidelines, and translational research aiming to improve patient outcomes.

Best Publications

  • State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

    Nicole C Foster;Roy W Beck;Kellee M Miller;Mark A Clements

  • Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

    Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal

  • Type 1 diabetes.

    Linda A DiMeglio;Carmella Evans-Molina;Richard A Oram

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Kevan C. Herold;Brian N. Bundy;S. Alice Long;Jeffrey A. Bluestone

  • Consensus Statement: Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

    Craig F. Munns;Nick Shaw;Mairead Kiely;Bonny L. Specker

  • Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

    Craig F. Munns;Nick Shaw;Mairead Kiely;Bonny L. Specker

  • ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

    Linda A. DiMeglio;Carlo L. Acerini;Ethel Codner;Maria E. Craig

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

    Jamie R. Wood;Kellee M. Miller;David M. Maahs;Roy W. Beck

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

    Antoinette Moran;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

    Manuela Battaglia;Simi Ahmed;Mark S. Anderson;Mark A. Atkinson

  • Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes

    Steven M. Willi;Kellee M. Miller;Linda A. DiMeglio;Georgeanna J. Klingensmith

  • Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Mark R. Rigby;Kristina M. Harris;Ashley Pinckney;Linda A. DiMeglio

  • Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels

    Richard M Bergenstal;Robin L Gal;Crystal G Connor;Rose Gubitosi-Klug

  • Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency : A meta-analysis

    Erica A. Eugster;Linda A. DiMeglio;James C. Wright;Gary R. Freidenberg

  • Prevalence of Detectable C-peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

    Asa K. Davis;Stephanie N. DuBose;Michael J. Haller;Kellee M. Miller

  • A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

    Linda A. DiMeglio;Tina M. Pottorff;Sheryl R. Boyd

  • Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.

    Calvin C Wu;Michael J Econs;Linda A DiMeglio;Karl L Insogna

  • Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Mark R. Rigby;Kristina M. Harris;Ashley Pinckney;Linda A. DiMeglio

Frequent Co-Authors

Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
William V. Tamborlane
William V. Tamborlane Yale University
Jay S. Skyler
Jay S. Skyler University of Miami
Desmond A. Schatz
Desmond A. Schatz University of Florida
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Roy W. Beck
Roy W. Beck University of South Florida
Kevan C. Herold
Kevan C. Herold Yale University
David M. Maahs
David M. Maahs Stanford University
Janice S. Blum
Janice S. Blum Indiana University
Mark A. Atkinson
Mark A. Atkinson University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to numerous online degree options that complement or enhance your healthcare career. For those interested in preventative care and wellness, online degrees in nutrition provide the foundation to specialize in dietetics and health promotion.

Looking to move into healthcare leadership roles? The best online mha programs allow you to earn a Master of Healthcare Administration conveniently, preparing you for vital management positions in hospitals and clinics.

For registered nurses aiming to advance academically without intensive on-site requirements, you can consider rn bsn online programs no clinicals, which streamline your journey toward a Bachelor of Science in Nursing.

If you’re focused on reaching the highest level of clinical nursing leadership in the shortest time, accelerated dnp programs offer rigorous, fast-track pathways to a Doctor of Nursing Practice degree.

Each of these online pathways offers flexibility, career advancement, and the opportunity to specialize while balancing existing work or study commitments.

Best Scientists Citing Linda A. DiMeglio

Trending Scientists